Ruiz, M.
González, S.
Bonnet, C.
Deng, S. X.
Article History
Received: 27 January 2022
Accepted: 16 May 2022
First Online: 31 May 2022
Declarations
:
: The study was performed in accordance with the Declaration of Helsinki and the consent for use in research was obtained by the eye banks. The study was exempted by the University of California Los Angeles Institutional Review Board (IRB#12–000363).
: The authors give consent for the publication of this research work by Biomarker Research.
: No sponsor or funding organization had any role in the design or conduct of this research. SXD is consultant for Claris Biopharmaceuticals, Kala Pharmaceuticals, Novartis and Dompe US. MR, SG and CB declare no competing interests.